Read + Share
Amedeo Smart
Independent Medical Education
. Cutler C, Lee SJ, Arai S, et al. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar study. Blood. 2021;138(22):2278-2289. Blood 2022;139:1772.PMID: 35298600
Email
LinkedIn
Facebook
Twitter
Privacy Policy